Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 12/20 | 0.60 |
| ▸ | RBP4 | P02753 | 3/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6107827 | 0.99 | HCAR2 (0.59) | HCAR2RBP4CYP2D6CYP2C19KDM4E | |
| SCHEMBL6105616 | 0.86 | KDM4E (0.73) | RBP4KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL6107814 | 0.83 | HCAR2 (0.54) | HCAR2RBP4CYP2D6CYP2C19KDM4E | |
| SCHEMBL10245047 | 0.81 | KDM4E (0.65) | RBP4CYP2C19KDM4EALDH1A1HPGD | |
| SCHEMBL10282564 | 0.80 | KDM4E (0.73) | RBP4KDM4EALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL10245197 | 0.80 | KDM4E (0.51) | KDM4EALDH1A1HSD17B10HPGDALOX12 | |
| SCHEMBL14032242 | 0.79 | RBP4 (0.61) | HCAR2RBP4CYP2D6CYP2C19KDM4E | |
| SCHEMBL14582622 | 0.78 | ABCC1 (0.74) | HCAR2RBP4CYP2D6CYP2C19KDM4E | |
| SCHEMBL6108086 | 0.76 | F10 (0.59) | SMN1; SMN2 | |
| SCHEMBL14032693 | 0.76 | RBP4 (0.58) | HCAR2RBP4CYP2D6CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029874-A1 | Aromatic amides | BEIGHT DOUGLAS WADE (US) | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029874-A1 | Aromatic amides | F11, F12, F5 | HCAR2 1559/4885RBP4 4083/4885CYP2D6 829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.